Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05844891 · ClinicalTrials.gov registry record · NA

Telehealth-Enhanced Asthma Care for Home After the Emergency Room

A NA study of Asthma in Children, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
430
Enrollment target
1
Study location

NCT05844891: Recruiting NA study of Asthma in Children, sponsored by University of Rochester.

NCT05844891 is a NA study of Asthma in Children that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 430 participants, above the 195-participant average among 44 other Asthma in Children trials with a reported enrollment target (121% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05844891, a NA study of Asthma in Children, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
430 participants
Enrollment target
1
Study location

Study Summary

The investigators propose a randomized controlled trial of Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER) vs. enhanced care (EC). TEACH-ER includes: 1) brief, pictorial, and health literacy-informed asthma education in the ED, with color- and shape-coded labels provided for home asthma medications; 2) virtual primary care follow-up within 1 week of discharge using in-home telemedicine (Zoom) when possible, featuring provider prompts for guideline-based preventive therapy and home delivery of prescribed medications with pictorial action plans; 3) two additional in-home virtual visits to reinforce teaching, review treatment plans, label medications, and support effective management practices. The investigators will enroll 430 children (ages 3-12 yrs) from the two dedicated pediatric EDs in our region, and follow all participants for a 12-month period. The investigators will call caregivers to complete blinded follow-up telephone surveys at 3, 6, 9, and 12 months after discharge. The investigators will assess the effectiveness of TEACH-ER in reducing the need for additional asthma-related ED visits or hospitalizations in the 1-months after enrollment. Additional outcomes of interest include asthma symptoms, medication adherence, absenteeism from work and school, quality of life, and the delivery of care consistent with national asthma care guidelines.

Primary Outcome

Asthma-related hospitalizations or emergency department visits, and drawn from objective healthcare utilization data in the electronic health record

Conditions Studied

Interventions

  • BEHAVIORAL Enhanced Care (EC)
  • BEHAVIORAL Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER)

Study Locations (1)

New York

  • University of Rochester Medical Center - Rochester

Trial Details

FieldValue
Enrollment Target 430 participants
Start Date 2024-04-01
Est. Completion 2028-06-30
Phase NA
University of Rochester

636 total trials

What NCT05844891 shows while recruiting

NCT05844891 is an interventional study that assigns participants to a tested intervention. The registered 430 participants enrollment target is mid-sized for trials with a published cap, above the 195-participant average among 44 other Asthma in Children trials with a reported enrollment target (121% higher).

The record links to 1 condition, with Asthma in Children appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Care (EC) is the first listed.

NCT05844891 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05844891 about?

NCT05844891 is a clinical study titled "Telehealth-Enhanced Asthma Care for Home After the Emergency Room". The investigators propose a randomized controlled trial of Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER) vs. enhanced care (EC). TEACH-ER includes: 1) brief, pictorial, and health literacy-informed asthma education in the ED, with color- and shape-coded labels provided...

What is the current status of trial NCT05844891?

This trial is currently recruiting. It is a NA study. The enrollment target is 430 participants. The study started on 2024-04-01. Estimated completion is 2028-06-30.

What conditions does trial NCT05844891 study?

This clinical trial studies the following conditions: Asthma in Children.

What interventions are being tested in trial NCT05844891?

The interventions under investigation include: Enhanced Care (EC) (BEHAVIORAL), Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05844891?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05844891 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma in Children

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05844891's enrollment target sits among peer trials

430 8th of 44 higher than 37 of 44 other Asthma in Children trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Asthma in Children trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05327023 · 430 participants · Phase 1

    Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

  • NCT05457985 · 430 participants · NA

    Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers

  • NCT05532982 · 430 participants

    Parkinson's Disease in Asian Americans

  • NCT05867251 · 430 participants · Phase 1

    Study of AVZO-021 in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05844891, the US trial registry maintained by the National Library of Medicine. NCT05844891 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.